Related references
Note: Only part of the references are listed.Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection
Lin Xia et al.
ONCOTARGET (2017)
Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
Gillian M. Keating
BIODRUGS (2016)
The herpes zoster subunit vaccine
Anthony L. Cunningham
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
A replication-defective human cytomegalovirus vaccine for prevention of congenital infection
Dai Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes
John W. Loughney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review
Ella J. Ariza-Heredia et al.
CANCER LETTERS (2014)
Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice
Chaoyang Huang et al.
VIROLOGY JOURNAL (2014)
Slow Increase in IgG Avidity Correlates With Prevention of Human Cytomegalovirus Transmission to the Fetus
Milena Furione et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
HSV-2 vaccine: Current state and insights into development of a vaccine that targets genital mucosal protection
Kristy Roth et al.
MICROBIAL PATHOGENESIS (2013)
Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection
Daniele Lilleri et al.
PLOS ONE (2013)
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
Daniel C. Freed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies
Rebecca J. Loomis et al.
VACCINE (2013)
Human Cytomegalovirus (HCMV) Glycoprotein gB Promotes Virus Entry In Trans Acting as the Viral Fusion Protein Rather than as a Receptor-Binding Protein
Paul T. Wille et al.
MBIO (2013)
Endothelial cells and CMV dissemination
Giuseppe Gerna
FUTURE MICROBIOLOGY (2012)
Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin
Ashley E. Fouts et al.
JOURNAL OF VIROLOGY (2012)
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial
Mohamed A. Kharfan-Dabaja et al.
LANCET INFECTIOUS DISEASES (2012)
Decoding Human Cytomegalovirus
Noam Stern-Ginossar et al.
SCIENCE (2012)
Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus
Tong-Ming Fu et al.
VACCINE (2012)
Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment
Elena Beam et al.
CURRENT INFECTIOUS DISEASE REPORTS (2012)
Neutralizing Activity of Saliva against Cytomegalovirus
Frances M. Saccoccio et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Cytomegalovirus: pathogen, paradigm, and puzzle
Michael Boeckh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women
Steffanie Sabbaj et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
Paul D. Griffiths et al.
LANCET (2011)
Congenital Cytomegalovirus Infection as a Cause of Sensorineural Hearing Loss in a Highly Immune Population
Aparecida Y. Yamamoto et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
High-resolution human cytomegalovirus transcriptome
Derek Gatherer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
Frances M. Saccoccio et al.
VACCINE (2011)
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection
Dai Wang et al.
VACCINE (2011)
B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
Sonja Poetzsch et al.
PLOS PATHOGENS (2011)
Human cytomegalovirus in utero transmission: Follow-up of 524 maternal seroconversions
Monique Bodeus et al.
JOURNAL OF CLINICAL VIROLOGY (2010)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex
Annalisa Macagno et al.
JOURNAL OF VIROLOGY (2010)
Management of cytomegalovirus infection in solid organ transplantation
Camille N. Kotton
NATURE REVIEWS NEPHROLOGY (2010)
Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications
M. Grazia Revello et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)-Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients
Michelle A. Barron et al.
CLINICAL INFECTIOUS DISEASES (2009)
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169
Amanda J. Bradley et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Vaccine Prevention of Maternal Cytomegalovirus Infection
Robert F. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain)
Mark A. Jacobson et al.
VACCINE (2009)
Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection
Giuseppe Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection
Xiaohong Cui et al.
VACCINE (2008)
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus
Elizabeth A. Reap et al.
VACCINE (2007)
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Aileen Kenneson et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects
Stefanie L. Slezak et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection
Sheila C. Dollard et al.
REVIEWS IN MEDICAL VIROLOGY (2007)
Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease
Renato La Torre et al.
CLINICAL INFECTIOUS DISEASES (2006)
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines
TC Heineman et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection
ZD Wang et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity
SA Ross et al.
JOURNAL OF PEDIATRICS (2006)
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients
MA Jacobson et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Human cytomegalovirus vaccine: time to look for alternative options
R Khanna et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism
D Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
I. Poloxamer- formulated plasmid DNA-based human cytomegalovirus vaccine: Evaluation of plasmid DNA biodistribution/persistence and integration
A Vilalta et al.
HUMAN GENE THERAPY (2005)
Passive immunization during pregnancy for congenital cytomegalovirus infection
G Nigro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism
D Wang et al.
JOURNAL OF VIROLOGY (2005)
Progress toward an elusive goal: current status of cytomegalovirus vaccines
Mark R. Schleiss et al.
EXPERT REVIEW OF VACCINES (2005)
Intranasal immunization with a replication-deficient adenovirus vector expressing glycoprotein H of murine cytomegalovirus induces mucosal and systemic immunity
JD Shanley et al.
VACCINE (2005)
Systemic priming-boosting immunization with a trivalent plasmid DNA and inactivated murine cytomegalovirus (MCMV) vaccine provides long-term protection against viral replication following systemic or mucosal MCMV challenge
CS Morello et al.
JOURNAL OF VIROLOGY (2005)
Genetic content of wild-type human cytomegalovirus
A Dolan et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes
G Hahn et al.
JOURNAL OF VIROLOGY (2004)
Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine
CP Zhang et al.
VACCINE (2004)
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome
SM Varnum et al.
JOURNAL OF VIROLOGY (2004)
Receptors and immune sensors: the complex entry path of human cytomegalovirus
T Compton
TRENDS IN CELL BIOLOGY (2004)
Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence
MS Smith et al.
JOURNAL OF VIROLOGY (2004)
Coding potential of laboratory and clinical strains of human cytomegalovirus
E Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Functional profiling of a human cytomegalovirus genome
W Dunn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Functional map of human cytomegalovirus AD169 defined by global mutational analysis
D Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mucosal immunization with a replication-deficient adenovirus vector expressing murine cytomegalovirus glycoprotein B induces mucosal and systemic immunity
JD Shanley et al.
VACCINE (2003)
The human cytomegalovirus
S Landolfo et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Rescue of human cytomegalovirus strain AD169 tropism for both leukocytes and human endothelial cells
G Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Maternal immunity and prevention of congenital cytomegalovirus infection
KB Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant
MG Revello et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
The attenuated Towne strain of human cytomegalovirus may revert to both endothelial cell tropism and leuko- (neutrophil- and monocyte-) tropism in vitro
G Gerna et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Immunisation of balb/c mice with severely attenuated murine cytomegalovirus mutants induces protective cellular and humoral immunity
PJ Morley et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers
DK Mitchell et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults
DI Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects
K Berencsi et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression
S Pepperl et al.
JOURNAL OF VIROLOGY (2000)
T-cell therapy of cytomegalovirus and human immunodeficiency virus infection
SR Riddell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
